|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Diabetes Research Laboratory, Winthrop University Hospital, Mineola, NY, USA
2 Department of Biology, York University, Ontario, Toronto, Canada
3 Diabetes Research Laboratory, Winthrop University Hospital, Mineola, NY, USA; School of Medicine, SUNY at Stony Brook, Stony Brook, NY, USA
* To whom correspondence should be addressed. E-mail: nbegum{at}winthrop.org.
Elevated levels of resistin have been proposed to cause insulin resistance and therefore, may serve as a link between obesity and type 2 diabetes. However, its role in skeletal muscle metabolism is unknown. In this study, we examined the effect of resistin on insulin-stimulated glucose uptake as well as the upstream insulin signaling components in L6 rat skeletal muscle cells that were either incubated with recombinant resistin or stably transfected with a vector containing the myc-tagged mouse resistin gene. Transfected clones expressed intracellular resistin which was released in the medium. Incubation with recombinant resistin resulted in a dose-dependent inhibition of insulin-stimulated 2-deoxyglucose (2-DOG) uptake due to reductions in the apparent Vmax. The inhibitory effect of resistin on insulin-stimulated 2-DOG uptake was not due to impaired Glut-4 translocation to the plasma membrane. Furthermore, resistin did not alter the IR content and its phosphorylation, nor did it affect insulin-stimulated IRS-1 tyrosine phosphorylation, its association with p85 subunit of PI3-kinase and IRS-1 associated PI3-kinase enzymatic activity. Insulin-stimulated phosphorylation of Akt/PKB-
, one of the downstream targets of PI3-kinase as well as p38MAPK phosphorylation was also not affected by resistin. Expression of resistin also inhibited insulin-stimulated DOG uptake when compared to cells expressing the empty vector (L6Neo) without affecting Glut-4 translocation, Glut-1 content and IRS-1/PI3-kinase signaling. We conclude that resistin does not alter insulin receptor signaling but does affect insulin-stimulated glucose uptake by decreasing the intrinsic activity of cell surface glucose transporters.
This article has been cited by other articles:
![]() |
M.-J. Lee, H. Lin, C.-W. Liu, M.-H. Wu, W.-J. Liao, H.-H. Chang, H.-C. Ku, Y.-S. Chien, W.-H. Ding, and Y.-H. Kao Octylphenol stimulates resistin gene expression in 3T3-L1 adipocytes via the estrogen receptor and extracellular signal-regulated kinase pathways Am J Physiol Cell Physiol, June 1, 2008; 294(6): C1542 - C1551. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Alkhateeb, A. Chabowski, J. F. C. Glatz, J. F. P. Luiken, and A. Bonen Two phases of palmitate-induced insulin resistance in skeletal muscle: impaired GLUT4 translocation is followed by a reduced GLUT4 intrinsic activity Am J Physiol Endocrinol Metab, September 1, 2007; 293(3): E783 - E793. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Haugen, T. Ranheim, N. K. Harsem, E. Lips, A. C. Staff, and C. A. Drevon Increased plasma levels of adipokines in preeclampsia: relationship to placenta and adipose tissue gene expression Am J Physiol Endocrinol Metab, February 1, 2006; 290(2): E326 - E333. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-S. Liu, Y.-H. Chen, P.-F. Hung, and Y.-H. Kao Inhibitory effect of green tea (-)-epigallocatechin gallate on resistin gene expression in 3T3-L1 adipocytes depends on the ERK pathway Am J Physiol Endocrinol Metab, February 1, 2006; 290(2): E273 - E281. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Mitchell, D T Armstrong, R L Robker, and R J Norman Adipokines: implications for female fertility and obesity Reproduction, November 1, 2005; 130(5): 583 - 597. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-H. Chen, P.-F. Hung, and Y.-H. Kao IGF-I downregulates resistin gene expression and protein secretion Am J Physiol Endocrinol Metab, May 1, 2005; 288(5): E1019 - E1027. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Kurlawalla-Martinez, B. Stiles, Y. Wang, S. U. Devaskar, B. B. Kahn, and H. Wu Insulin Hypersensitivity and Resistance to Streptozotocin-Induced Diabetes in Mice Lacking PTEN in Adipose Tissue Mol. Cell. Biol., March 15, 2005; 25(6): 2498 - 2510. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Haugen, N. Zahid, K. T. Dalen, K. Hollung, H. I. Nebb, and C. A. Drevon Resistin expression in 3T3-L1 adipocytes is reduced by arachidonic acid J. Lipid Res., January 1, 2005; 46(1): 143 - 153. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W. Rajala, Y. Qi, H. R. Patel, N. Takahashi, R. Banerjee, U. B. Pajvani, M. K. Sinha, R. L. Gingerich, P. E. Scherer, and R. S. Ahima Regulation of Resistin Expression and Circulating Levels in Obesity, Diabetes, and Fasting Diabetes, July 1, 2004; 53(7): 1671 - 1679. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. R. Banerjee, S. M. Rangwala, J. S. Shapiro, A. S. Rich, B. Rhoades, Y. Qi, J. Wang, M. W. Rajala, A. Pocai, P. E. Scherer, et al. Regulation of Fasted Blood Glucose by Resistin Science, February 20, 2004; 303(5661): 1195 - 1198. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |